| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_840e3673e962dde3e5975e5c8d3483a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_785b1af8eb506594cac30185363dd44d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cb5dda68dd28f2b3928fab6e558a445 |
| publicationDate |
2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2625527-A1 |
| titleOfInvention |
Method for assessing the efficacy of a tr1 cell therapy in a subject |
| abstract |
The present invention relates to a method for assessing whether a patient subjected to an antigen-specific Trl cell therapy is responding to the treatment, said method comprising: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from said patient, comparing said antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment. |
| priorityDate |
2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |